Surgery Partners (SGRY) Shares Outstanding (2014 - 2026)

Surgery Partners has disclosed Shares Outstanding (Entity) across 13 years of filings, most recently posting $130.9 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 2.09% year-over-year to $130.9 million; the TTM figure through Jun 2026 stood at $130.9 million (up 2.09% YoY), while the FY2025 annual figure was $129.3 million, up 1.74% from the prior year.
• Shares Outstanding (Entity) came in at $130.9 million for Q2 2026 at Surgery Partners, roughly flat from $130.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $130.9 million in Q2 2026 to a low of $89.9 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $119.6 million, with a median of $127.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) soared 50.09% in 2022 and increased 0.41% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $92.0 million in 2022, then jumped by 37.67% to $126.6 million in 2023, then climbed by 0.41% to $127.1 million in 2024, then rose by 1.74% to $129.3 million in 2025, then rose by 1.21% to $130.9 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $130.9 million in Q2 2026, $130.8 million in Q1 2026, and $129.3 million in Q4 2025.